| GO:0070062 | extracellular vesicular exosome | 2.63e-04 | 1.00e+00 | 2.073 | 7 | 104 | 2400 | 
| GO:0016032 | viral process | 3.27e-04 | 1.00e+00 | 3.433 | 4 | 55 | 534 | 
| GO:0005829 | cytosol | 3.39e-04 | 1.00e+00 | 2.016 | 7 | 132 | 2496 | 
| GO:0006412 | translation | 4.42e-04 | 1.00e+00 | 4.234 | 3 | 20 | 230 | 
| GO:0003725 | double-stranded RNA binding | 5.63e-04 | 1.00e+00 | 5.794 | 2 | 5 | 52 | 
| GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:1901227 | negative regulation of transcription from RNA polymerase II promoter involved in heart development | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:0005854 | nascent polypeptide-associated complex | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:0048291 | isotype switching to IgG isotypes | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:0019521 | D-gluconate metabolic process | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:0002368 | B cell cytokine production | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 | 
| GO:0043234 | protein complex | 9.14e-04 | 1.00e+00 | 3.875 | 3 | 18 | 295 | 
| GO:0050794 | regulation of cellular process | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0002176 | male germ cell proliferation | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0019322 | pentose biosynthetic process | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 2 | 2 | 
| GO:0003994 | aconitate hydratase activity | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0005055 | laminin receptor activity | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0006407 | rRNA export from nucleus | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0048633 | positive regulation of skeletal muscle tissue growth | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 | 
| GO:0005850 | eukaryotic translation initiation factor 2 complex | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:1900126 | negative regulation of hyaluronan biosynthetic process | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 | 
| GO:0006458 | 'de novo' protein folding | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:0090188 | negative regulation of pancreatic juice secretion | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:0061384 | heart trabecula morphogenesis | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:0003231 | cardiac ventricle development | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 | 
| GO:0030135 | coated vesicle | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 | 
| GO:0071439 | clathrin complex | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 | 
| GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 | 
| GO:0030686 | 90S preribosome | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 | 
| GO:0032051 | clathrin light chain binding | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 | 
| GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 | 
| GO:1903077 | negative regulation of protein localization to plasma membrane | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 | 
| GO:0010664 | negative regulation of striated muscle cell apoptotic process | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 | 
| GO:0016020 | membrane | 3.25e-03 | 1.00e+00 | 2.101 | 5 | 90 | 1681 | 
| GO:0048742 | regulation of skeletal muscle fiber development | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 | 
| GO:0043248 | proteasome assembly | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 | 
| GO:0046696 | lipopolysaccharide receptor complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 | 
| GO:0006102 | isocitrate metabolic process | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 | 
| GO:0006413 | translational initiation | 3.51e-03 | 1.00e+00 | 4.461 | 2 | 17 | 131 | 
| GO:0044267 | cellular protein metabolic process | 3.56e-03 | 1.00e+00 | 3.190 | 3 | 29 | 474 | 
| GO:0003688 | DNA replication origin binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 6 | 
| GO:0030130 | clathrin coat of trans-Golgi network vesicle | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 6 | 
| GO:0030957 | Tat protein binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 6 | 
| GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 | 
| GO:0006101 | citrate metabolic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 | 
| GO:0030118 | clathrin coat | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 6 | 
| GO:0044822 | poly(A) RNA binding | 4.19e-03 | 1.00e+00 | 2.450 | 4 | 49 | 1056 | 
| GO:0061024 | membrane organization | 4.28e-03 | 1.00e+00 | 4.314 | 2 | 7 | 145 | 
| GO:0030132 | clathrin coat of coated pit | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 7 | 
| GO:0000028 | ribosomal small subunit assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 | 
| GO:0003084 | positive regulation of systemic arterial blood pressure | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 | 
| GO:0070688 | MLL5-L complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 | 
| GO:0051604 | protein maturation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 | 
| GO:0019869 | chloride channel inhibitor activity | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 | 
| GO:0006098 | pentose-phosphate shunt | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 4 | 10 | 
| GO:0043032 | positive regulation of macrophage activation | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 1 | 10 | 
| GO:0032727 | positive regulation of interferon-alpha production | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 11 | 
| GO:0043403 | skeletal muscle tissue regeneration | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 11 | 
| GO:0005838 | proteasome regulatory particle | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 7 | 12 | 
| GO:0001530 | lipopolysaccharide binding | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 3 | 13 | 
| GO:0051131 | chaperone-mediated protein complex assembly | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 13 | 
| GO:0010467 | gene expression | 9.33e-03 | 1.00e+00 | 2.693 | 3 | 59 | 669 | 
| GO:0035267 | NuA4 histone acetyltransferase complex | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 4 | 14 | 
| GO:0016071 | mRNA metabolic process | 9.87e-03 | 1.00e+00 | 3.693 | 2 | 31 | 223 | 
| GO:0005759 | mitochondrial matrix | 1.03e-02 | 1.00e+00 | 3.661 | 2 | 14 | 228 | 
| GO:0042026 | protein refolding | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 15 | 
| GO:0050998 | nitric-oxide synthase binding | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 | 
| GO:0017025 | TBP-class protein binding | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 3 | 17 | 
| GO:0050870 | positive regulation of T cell activation | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 17 | 
| GO:0022624 | proteasome accessory complex | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 8 | 17 | 
| GO:0016070 | RNA metabolic process | 1.20e-02 | 1.00e+00 | 3.546 | 2 | 32 | 247 | 
| GO:0032733 | positive regulation of interleukin-10 production | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 1 | 19 | 
| GO:0048863 | stem cell differentiation | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 1 | 19 | 
| GO:0042100 | B cell proliferation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 21 | 
| GO:0004860 | protein kinase inhibitor activity | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 21 | 
| GO:0030863 | cortical cytoskeleton | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 22 | 
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 4 | 22 | 
| GO:0043044 | ATP-dependent chromatin remodeling | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 4 | 23 | 
| GO:0043236 | laminin binding | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 | 
| GO:0008135 | translation factor activity, nucleic acid binding | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 7 | 24 | 
| GO:0005515 | protein binding | 1.65e-02 | 1.00e+00 | 0.938 | 8 | 184 | 6024 | 
| GO:0042113 | B cell activation | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 2 | 25 | 
| GO:0032735 | positive regulation of interleukin-12 production | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 1 | 25 | 
| GO:0043022 | ribosome binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 3 | 27 | 
| GO:0050661 | NADP binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 27 | 
| GO:0031492 | nucleosomal DNA binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 4 | 27 | 
| GO:0019901 | protein kinase binding | 1.93e-02 | 1.00e+00 | 3.186 | 2 | 21 | 317 | 
| GO:0006099 | tricarboxylic acid cycle | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 4 | 28 | 
| GO:0030669 | clathrin-coated endocytic vesicle membrane | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 4 | 28 | 
| GO:0019894 | kinesin binding | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 28 | 
| GO:0033572 | transferrin transport | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 30 | 
| GO:0031623 | receptor internalization | 2.13e-02 | 1.00e+00 | 5.540 | 1 | 2 | 31 | 
| GO:0032588 | trans-Golgi network membrane | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 2 | 34 | 
| GO:0001895 | retina homeostasis | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 34 | 
| GO:0048666 | neuron development | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 2 | 34 | 
| GO:0051539 | 4 iron, 4 sulfur cluster binding | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 35 | 
| GO:0034332 | adherens junction organization | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 36 | 
| GO:0032755 | positive regulation of interleukin-6 production | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 36 | 
| GO:0005925 | focal adhesion | 2.53e-02 | 1.00e+00 | 2.978 | 2 | 19 | 366 | 
| GO:0018107 | peptidyl-threonine phosphorylation | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 4 | 37 | 
| GO:0051084 | 'de novo' posttranslational protein folding | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 4 | 37 | 
| GO:0070527 | platelet aggregation | 2.60e-02 | 1.00e+00 | 5.246 | 1 | 2 | 38 | 
| GO:0032729 | positive regulation of interferon-gamma production | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 39 | 
| GO:0022627 | cytosolic small ribosomal subunit | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 4 | 39 | 
| GO:0042110 | T cell activation | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 3 | 42 | 
| GO:0030136 | clathrin-coated vesicle | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 4 | 42 | 
| GO:0019902 | phosphatase binding | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 2 | 42 | 
| GO:0006892 | post-Golgi vesicle-mediated transport | 2.94e-02 | 1.00e+00 | 5.068 | 1 | 3 | 43 | 
| GO:0021762 | substantia nigra development | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 2 | 44 | 
| GO:0010923 | negative regulation of phosphatase activity | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 48 | 
| GO:0043066 | negative regulation of apoptotic process | 3.32e-02 | 1.00e+00 | 2.766 | 2 | 31 | 424 | 
| GO:0003743 | translation initiation factor activity | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 8 | 49 | 
| GO:0006091 | generation of precursor metabolites and energy | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 50 | 
| GO:0006521 | regulation of cellular amino acid metabolic process | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 17 | 50 | 
| GO:0006986 | response to unfolded protein | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 2 | 50 | 
| GO:0005905 | coated pit | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 50 | 
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 5 | 53 | 
| GO:0045216 | cell-cell junction organization | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 54 | 
| GO:0002039 | p53 binding | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 7 | 55 | 
| GO:0000502 | proteasome complex | 3.95e-02 | 1.00e+00 | 4.636 | 1 | 17 | 58 | 
| GO:0051087 | chaperone binding | 4.02e-02 | 1.00e+00 | 4.612 | 1 | 6 | 59 | 
| GO:0030141 | secretory granule | 4.22e-02 | 1.00e+00 | 4.540 | 1 | 2 | 62 | 
| GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 19 | 64 | 
| GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 22 | 65 | 
| GO:0006469 | negative regulation of protein kinase activity | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 4 | 65 | 
| GO:0044281 | small molecule metabolic process | 4.53e-02 | 1.00e+00 | 1.837 | 3 | 58 | 1211 | 
| GO:0034329 | cell junction assembly | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 1 | 68 | 
| GO:0003697 | single-stranded DNA binding | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 5 | 68 | 
| GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 22 | 70 | 
| GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 20 | 72 | 
| GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 6 | 74 | 
| GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 22 | 74 | 
| GO:0008584 | male gonad development | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 3 | 75 | 
| GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 20 | 75 | 
| GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 7 | 77 | 
| GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.35e-02 | 1.00e+00 | 4.190 | 1 | 23 | 79 | 
| GO:0005524 | ATP binding | 5.40e-02 | 1.00e+00 | 1.737 | 3 | 60 | 1298 | 
| GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 3 | 80 | 
| GO:0019083 | viral transcription | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 10 | 81 | 
| GO:0006898 | receptor-mediated endocytosis | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 84 | 
| GO:0006415 | translational termination | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 10 | 87 | 
| GO:0050821 | protein stabilization | 5.94e-02 | 1.00e+00 | 4.035 | 1 | 2 | 88 | 
| GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 6.07e-02 | 1.00e+00 | 4.002 | 1 | 7 | 90 | 
| GO:0042470 | melanosome | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 9 | 91 | 
| GO:0006928 | cellular component movement | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 7 | 91 | 
| GO:0005200 | structural constituent of cytoskeleton | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 8 | 91 | 
| GO:0001649 | osteoblast differentiation | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 6 | 92 | 
| GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 21 | 92 | 
| GO:0006414 | translational elongation | 6.27e-02 | 1.00e+00 | 3.955 | 1 | 13 | 93 | 
| GO:0051082 | unfolded protein binding | 6.27e-02 | 1.00e+00 | 3.955 | 1 | 5 | 93 | 
| GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 10 | 104 | 
| GO:0014069 | postsynaptic density | 7.05e-02 | 1.00e+00 | 3.780 | 1 | 3 | 105 | 
| GO:0005506 | iron ion binding | 7.05e-02 | 1.00e+00 | 3.780 | 1 | 4 | 105 | 
| GO:0006811 | ion transport | 7.18e-02 | 1.00e+00 | 3.753 | 1 | 1 | 107 | 
| GO:0072562 | blood microparticle | 7.44e-02 | 1.00e+00 | 3.700 | 1 | 3 | 111 | 
| GO:0030529 | ribonucleoprotein complex | 7.50e-02 | 1.00e+00 | 3.687 | 1 | 8 | 112 | 
| GO:0005819 | spindle | 7.50e-02 | 1.00e+00 | 3.687 | 1 | 7 | 112 | 
| GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.63e-02 | 1.00e+00 | 3.661 | 1 | 11 | 114 | 
| GO:0019058 | viral life cycle | 7.70e-02 | 1.00e+00 | 3.649 | 1 | 13 | 115 | 
| GO:0000209 | protein polyubiquitination | 7.76e-02 | 1.00e+00 | 3.636 | 1 | 20 | 116 | 
| GO:0044237 | cellular metabolic process | 7.82e-02 | 1.00e+00 | 3.624 | 1 | 5 | 117 | 
| GO:0006325 | chromatin organization | 7.89e-02 | 1.00e+00 | 3.612 | 1 | 5 | 118 | 
| GO:0006511 | ubiquitin-dependent protein catabolic process | 8.40e-02 | 1.00e+00 | 3.517 | 1 | 5 | 126 | 
| GO:0000790 | nuclear chromatin | 8.60e-02 | 1.00e+00 | 3.483 | 1 | 9 | 129 | 
| GO:0031982 | vesicle | 8.72e-02 | 1.00e+00 | 3.461 | 1 | 9 | 131 | 
| GO:0003735 | structural constituent of ribosome | 9.11e-02 | 1.00e+00 | 3.396 | 1 | 10 | 137 | 
| GO:0005737 | cytoplasm | 9.18e-02 | 1.00e+00 | 0.937 | 5 | 110 | 3767 | 
| GO:0016887 | ATPase activity | 9.30e-02 | 1.00e+00 | 3.365 | 1 | 7 | 140 | 
| GO:0006457 | protein folding | 9.49e-02 | 1.00e+00 | 3.334 | 1 | 7 | 143 | 
| GO:0000082 | G1/S transition of mitotic cell cycle | 9.87e-02 | 1.00e+00 | 3.275 | 1 | 32 | 149 | 
| GO:0005198 | structural molecule activity | 9.93e-02 | 1.00e+00 | 3.265 | 1 | 5 | 150 | 
| GO:0042981 | regulation of apoptotic process | 9.93e-02 | 1.00e+00 | 3.265 | 1 | 24 | 150 | 
| GO:0005769 | early endosome | 1.01e-01 | 1.00e+00 | 3.246 | 1 | 2 | 152 | 
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.09e-01 | 1.00e+00 | 3.128 | 1 | 7 | 165 | 
| GO:0030424 | axon | 1.09e-01 | 1.00e+00 | 3.119 | 1 | 4 | 166 | 
| GO:0006886 | intracellular protein transport | 1.12e-01 | 1.00e+00 | 3.076 | 1 | 5 | 171 | 
| GO:0034641 | cellular nitrogen compound metabolic process | 1.12e-01 | 1.00e+00 | 3.076 | 1 | 20 | 171 | 
| GO:0001701 | in utero embryonic development | 1.31e-01 | 1.00e+00 | 2.843 | 1 | 8 | 201 | 
| GO:0005615 | extracellular space | 1.39e-01 | 1.00e+00 | 1.592 | 2 | 17 | 957 | 
| GO:0007067 | mitotic nuclear division | 1.47e-01 | 1.00e+00 | 2.668 | 1 | 14 | 227 | 
| GO:0005739 | mitochondrion | 1.49e-01 | 1.00e+00 | 1.531 | 2 | 28 | 998 | 
| GO:0003713 | transcription coactivator activity | 1.53e-01 | 1.00e+00 | 2.605 | 1 | 10 | 237 | 
| GO:0005975 | carbohydrate metabolic process | 1.62e-01 | 1.00e+00 | 2.511 | 1 | 9 | 253 | 
| GO:0005654 | nucleoplasm | 1.70e-01 | 1.00e+00 | 1.415 | 2 | 76 | 1082 | 
| GO:0043065 | positive regulation of apoptotic process | 1.71e-01 | 1.00e+00 | 2.428 | 1 | 10 | 268 | 
| GO:0005743 | mitochondrial inner membrane | 1.76e-01 | 1.00e+00 | 2.380 | 1 | 8 | 277 | 
| GO:0005634 | nucleus | 1.79e-01 | 1.00e+00 | 0.662 | 5 | 136 | 4559 | 
| GO:0005856 | cytoskeleton | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 12 | 291 | 
| GO:0006200 | ATP catabolic process | 1.85e-01 | 1.00e+00 | 2.304 | 1 | 15 | 292 | 
| GO:0035556 | intracellular signal transduction | 1.91e-01 | 1.00e+00 | 2.251 | 1 | 9 | 303 | 
| GO:0004674 | protein serine/threonine kinase activity | 1.94e-01 | 1.00e+00 | 2.227 | 1 | 12 | 308 | 
| GO:0007411 | axon guidance | 2.00e-01 | 1.00e+00 | 2.177 | 1 | 13 | 319 | 
| GO:0015031 | protein transport | 2.13e-01 | 1.00e+00 | 2.081 | 1 | 5 | 341 | 
| GO:0003723 | RNA binding | 2.13e-01 | 1.00e+00 | 2.076 | 1 | 20 | 342 | 
| GO:0007155 | cell adhesion | 2.28e-01 | 1.00e+00 | 1.967 | 1 | 6 | 369 | 
| GO:0000278 | mitotic cell cycle | 2.40e-01 | 1.00e+00 | 1.883 | 1 | 48 | 391 | 
| GO:0009986 | cell surface | 2.46e-01 | 1.00e+00 | 1.843 | 1 | 11 | 402 | 
| GO:0055114 | oxidation-reduction process | 2.56e-01 | 1.00e+00 | 1.780 | 1 | 12 | 420 | 
| GO:0005886 | plasma membrane | 2.60e-01 | 1.00e+00 | 0.745 | 3 | 45 | 2582 | 
| GO:0007596 | blood coagulation | 2.74e-01 | 1.00e+00 | 1.664 | 1 | 18 | 455 | 
| GO:0006468 | protein phosphorylation | 2.77e-01 | 1.00e+00 | 1.649 | 1 | 18 | 460 | 
| GO:0006915 | apoptotic process | 3.25e-01 | 1.00e+00 | 1.378 | 1 | 33 | 555 | 
| GO:0045087 | innate immune response | 3.44e-01 | 1.00e+00 | 1.275 | 1 | 24 | 596 | 
| GO:0006355 | regulation of transcription, DNA-templated | 5.12e-01 | 1.00e+00 | 0.533 | 1 | 18 | 997 | 
| GO:0003677 | DNA binding | 5.86e-01 | 1.00e+00 | 0.244 | 1 | 28 | 1218 | 
| GO:0046872 | metal ion binding | 6.13e-01 | 1.00e+00 | 0.142 | 1 | 25 | 1307 | 
| GO:0006351 | transcription, DNA-templated | 6.52e-01 | 1.00e+00 | -0.004 | 1 | 31 | 1446 |